| Delftia acidovorans as an Unusual Causative Organism in Line-Related Sepsis KJ Lang, T Chinzowu, KJ Cann Indian journal of microbiology 52, 102-103, 2012 | 23 | 2012 |
| Bilateral hip fractures associated with transient osteoporosis of pregnancy S Lidder, KJ Lang, HJ Lee, S Masterson, RK Kankate BMJ Military Health 157 (2), 176-178, 2011 | 23 | 2011 |
| Tuberculosis of the knee S Lidder, K Lang, M Haroon, M Shahidi, M El-Guindi Orthopedic Reviews 1 (2), 2009 | 23 | 2009 |
| Rapidly evolving giant dermatofibroma KJ Lang, S Lidder, M Hofer, C Graham, A Taylor Case reports in medicine 2010 (1), 620910, 2010 | 18 | 2010 |
| Under-representation of the elderly in cancer clinical trials KJ Lang, S Lidder British Journal of Hospital Medicine 71 (12), 678-681, 2010 | 16 | 2010 |
| Acute spinal epidural haematoma causing cord compression after chiropractic neck manipulation: an under-recognised serious hazard? S Lidder, KJ Lang, S Masterson, S Blagg BMJ Military Health 156 (4), 255-257, 2010 | 15 | 2010 |
| Women administered standard dose imatinib for chronic myeloid leukemia have higher dose-adjusted plasma imatinib and norimatinib concentrations than men SL Belsey, R Ireland, K Lang, A Kizilors, A Ho, GJ Mufti, A Bisquera, ... Therapeutic drug monitoring 39 (5), 499-504, 2017 | 14 | 2017 |
| Changing paradigms in the management of deep vein thrombosis KJ Lang, P Saha, LN Roberts, R Arya British journal of haematology 170 (2), 162-174, 2015 | 13 | 2015 |
| Social preferences for health states associated with acute myeloid leukemia for patients undergoing treatment in the United Kingdom N Castejón, JC Cappelleri, J Cuervo, K Lang, P Mehta, R Mokgokong, ... Health and quality of life outcomes 16, 1-9, 2018 | 11 | 2018 |
| Oxford handbook of key clinical evidence K Kulkarni, J Harrison, M Baguneid, B Prendergast Oxford University Press, 2016 | 8 | 2016 |
| Massive pleural effusion due to IgG multiple myeloma KJ Lang, S Lidder, R Aitchison Hematology Reviews 1 (2), 2009 | 8 | 2009 |
| Basal cell carcinoma of the penis S Lidder, KJ Lang, A Nakhdjevani Singapore Med J 52 (10), e201-e202, 2011 | 7 | 2011 |
| A comparative evaluation of gemtuzumab ozogamicin+ daunorubicin-cytarabine and other treatments for newly diagnosed acute myeloid leukemia AO Ashaye, Z Khankhel, Y Xu, K Fahrbach, R Mokgokong, ME Orme, ... Future Oncology 15 (6), 663-681, 2018 | 5 | 2018 |
| Rivaroxaban-mediated vascular relaxation as a potential cause of headaches and dizziness J Mabley, G Scutt, KJ Lang, JP Patel, R Arya Blood 126 (23), 2334, 2015 | 4 | 2015 |
| Real-world rivaroxaban levels from King's college hospital K Lang, J Patel, P Chitongo, J Czuprynska, L Roberts, R Patel, R Arya Journal of Thrombosis and Haemostasis 13, 117-118, 2015 | 4 | 2015 |
| The value of computerised VTE assessments: findings from retrospective audit of 2474 non-consecutive electronic patient records in a VTE exemplar centre KJ Lang, RD Barker, LN Roberts, R Yorke, L Bonner, RK Patel, R Arya BRITISH JOURNAL OF HAEMATOLOGY 157, 31-31, 2012 | 3 | 2012 |
| Estimating health state utilities for patients with acute myeloid leukemia N Castejón, JC Cappelleri, J Cuervo, K Lang, P Mehta, R Mokgokong, ... Value in Health 20 (5), A224-A224, 2017 | 1 | 2017 |
| The first registry: follow-up in rivaroxaban patients in the setting of venous thromboembolism KJ Lang, V Solis, J Patel, J Czuprynska, LN Roberts, R Patel, R Arya Blood 126 (23), 4737, 2015 | 1 | 2015 |
| How do real-world apixaban concentrations compare to expected concentrations? H Yones, J Patel, P Chitongo, R Byrne, A Brown, M Watras, K Lang, ... Journal of Thrombosis and Haemostasis 13, 387-388, 2015 | 1 | 2015 |
| Ambulatory care of patients receiving consolidation chemotherapy for acute myeloid leukaemia: A feasible and safe option for selected patients K Lang, C Roughley, L Roberts, M Mohamed, V Ratnayake, K Saied, ... HAEMATOLOGICA 98, 519-520, 2013 | 1 | 2013 |
